The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The ...
Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...
Clinical trials for a revolutionary vaccine to treat acne will be conducted by the National Skin Centre in partnership with ...
About 200 people with the condition will be recruited for the trial, which will start in 2025. Read more at straitstimes.com.
The facility, known as Modulus, can switch between making different vaccines or treatments in a matter of days. It will contribute about 200 skilled jobs to Singapore, and will be fully ...
The facility, known as Modulus, can switch between making different vaccines or treatments in a matter of days. It will contribute about 200 skilled jobs to Singapore, and will be fully ...